Please login to the form below

Not currently logged in
Email:
Password:

Sun/ Merck enter Indian diabetes deal

Merck has teamed up with Sun Pharmaceutical to co-market Merck's diabetes drugs sitagliptin and sitagliptin plus metformin in India

Merck (known as MSD outside the US and Canada) has teamed up with Sun Pharmaceutical to co-market Merck's diabetes drugs, sitagliptin and sitagliptin plus metformin, in India.

Sitagliptin is currently marketed outside India as Januvia, and sitagliptin plus metformin is marketed as Janumet.

Under the agreement, Sun Pharma will have the rights to market, promote and distribute the drugs under different brand names in India.

Financial details of the agreement were not disclosed.

K G Ananthakrishnan, managing director, Merck in India, described increasing access to the drugs as an "urgent need" with increasingly high rates of type 2 diabetes in India.

S Kalyanasundaram, CEO, Sun Pharma also commented on the deal: "Through this partnership, the reach of sitagliptin and sitagliptin plus metformin will be enhanced amongst doctors and patients in India, helping them efficaciously manage the disease."

Sitagliptin is an oral antihyperglycaemic of the dipeptidyl peptidase-4 (DPP-4) inhibitor class.

Two of the scientists behind the drug's discovery were recently honoured by Pharmaceutical Research and Manufacturers of America (PhRMA) with its 2011 Discoverers Award.

26th April 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics